Genmab — Januar 2021
-
Simply Wall Street: Since institutional investors own more than half the issued stock, the board will likely have to pay attention to their preferences. Hedge funds don't have many shares in Genmab. Our data shows that Artisan Partners Limited Partnership is the largest shareholder with 7.7% of shares outstanding. Baillie Gifford & Co. is the second largest shareholder owning 5.5% of common stock, and BlackRock, Inc. holds about 5.3% of the company stock. In addition, we found that Jan G. van
-
de Winkel, the CEO has 1.0% of the shares allocated to their name.
A deeper look at our ownership data shows that the top 25 shareholders collectively hold less than half of the register, suggesting a large group of small holders where no single shareholder has a majority.
-
God morgen.

-
-
Danske Bank om Ugen, der kommer – og
Ugen, der gik: https://www.proinvestor.com/investornyt/671619/danske-bank-om-ugen-der-kommer-og-ugen-der-gik -
https://www.etf.com/stock/GMAB her Genmab ADR som er at finde i 9 US ETFer
-
Vanguard ETF Overview https://www.etf.com/channels/vanguard-etfs
-
Større skriv i P&P om pharma/biotek - dernævnes 8 spændendr selskaber: CRISPR Thera., Intellia, Editas,Nanoform, V
-
Orphazyme, Genmab, ARK, Novo
-
Citi om Genmab-succes i lungekræft: Kan være op mod 20 mia. kr. værd
Genmab og partneren Janssen Pharmaceuticals kan have en god behandling på vej mod sjælden type af lungekræft, og Citi ser stor værdi i projektet En ny kræftbehandling, udviklet af biotekselskabet Genm
borsen.dk (borsen.dk)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind